# Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora

> **NCT01192802** · PHASE4 · COMPLETED · sponsor: **Albert Schweitzer Hospital** · enrollment: 200 (actual)

## Conditions studied

- Intestinal Diseases
- Helminthiasis

## Interventions

- **DRUG:** albendazole
- **DRUG:** albendazole
- **DRUG:** albendazole

## Key facts

- **NCT ID:** NCT01192802
- **Lead sponsor:** Albert Schweitzer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2013-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01192802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01192802, "Efficacy of Albendazole to Treat Intestinal Helminths and Its Effect on Gut Microflora". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01192802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*